Jinghua Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000L14
CNY
6.48
-0.06 (-0.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
379.76
367.67
360.86
367.89
363.54
356.92
324.86
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
379.76
367.67
360.86
367.89
363.54
356.92
324.86
Raw Material Cost
169.42
189.68
182.17
168.96
179.91
186.26
174.58
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.12
0.12
0.00
0.23
0.23
0.00
0.61
Selling and Distribution Expenses
98.46
95.91
101.39
93.64
89.35
94.28
93.80
Other Expenses
1.42
2.03
1.37
1.72
0.94
1.37
1.31
Total Expenditure (Excl Depreciation)
282.17
306.02
297.23
280.06
278.86
294.22
282.06
Operating Profit (PBDIT) excl Other Income
97.6
61.7
63.6
87.8
84.7
62.699999999999996
42.800000000000004
Other Income
5.57
9.27
9.22
9.73
7.75
24.89
5.63
Operating Profit (PBDIT)
93.30
80.28
86.90
108.55
100.31
84.39
60.11
Interest
0.12
0.12
0.00
0.23
0.23
0.00
0.61
Exceptional Items
1.32
1.05
1.67
0.67
0.78
0.16
0.25
Gross Profit (PBDT)
210.35
177.99
178.70
198.92
183.63
170.65
150.28
Depreciation
0.00
20.66
20.66
17.36
17.36
16.44
16.44
Profit Before Tax
94.49
60.56
67.91
91.63
83.51
68.11
43.31
Tax
12.74
8.28
10.05
11.46
11.99
11.15
7.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
65.87
42.91
45.73
68.42
62.22
48.42
28.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
65.87
42.91
45.73
68.42
62.22
48.42
28.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
15.88
9.37
12.14
11.74
9.30
8.54
6.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
81.75
52.28
57.87
80.17
71.52
56.96
35.60
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,824.44
2,752.71
2,706.15
2,654.86
2,647.31
2,583.50
2,535.75
Earnings per share (EPS)
0.08
0.05
0.06
0.08
0.08
0.06
0.04
Diluted Earnings per share
0.08
0.05
0.06
0.08
0.08
0.06
0.04
Operating Profit Margin (Excl OI)
23.1%
13.7%
15.8%
22.14%
20.69%
12.06%
11.71%
Gross Profit Margin
24.88%
22.09%
24.54%
29.62%
27.75%
23.69%
18.39%
PAT Margin
17.35%
11.67%
12.67%
18.6%
17.12%
13.57%
8.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 3.29% vs 1.88% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 56.21% vs -9.67% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 23.52% vs -8.62% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Jinghua Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
379.76
0
379.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
379.76
0
379.76
Raw Material Cost
169.42
0
169.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.12
0
0.12
Selling and Distribution Expenses
98.46
0
98.46
Other Expenses
1.42
0.00
1.42
Total Expenditure (Excl Depreciation)
282.17
0
282.17
Operating Profit (PBDIT) excl Other Income
97.60
0.00
97.60
Other Income
5.57
0
5.57
Operating Profit (PBDIT)
93.30
0
93.30
Interest
0.12
0
0.12
Exceptional Items
1.32
0
1.32
Gross Profit (PBDT)
210.35
0
210.35
Depreciation
0.00
0
0.00
Profit Before Tax
94.49
0
94.49
Tax
12.74
0
12.74
Provisions and contingencies
0
0
0.00
Profit After Tax
65.87
0
65.87
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
65.87
0
65.87
Share in Profit of Associates
0
0
0.00
Minority Interest
15.88
0
15.88
Other related items
0.00
0.00
0.00
Consolidated Net Profit
81.75
0
81.75
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,824.44
0
2,824.44
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
23.10%
0%
0.00
23.10%
Gross Profit Margin
24.88%
0%
0.00
24.88%
PAT Margin
17.35%
0%
0.00
17.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 37.98 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 3.29% vs 1.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.48% vs -0.98% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.17 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 56.21% vs -9.67% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 14.27% vs -12.80% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.77 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 23.52% vs -8.62% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -5.29% vs -3.34% in Mar 2025

Quarterly - Interest
Interest 0.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -50.00% vs -71.43% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.10%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025